SREBP‐1c is usually upregulated in HFD‐induced obese mice (Yang et al., 2021); the inhibition of SREBP activity could attenuate hepatic steatosis and atherosclerosis in diet‐induced insulin‐resistant mice (Ho et al., 2019; Li et al., 2011). Here, SREBF1 is linked to Hepatic steatosis.